(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine
|
- $207 - $896
- Product name: (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine
- CAS: 457097-82-4
- MF: C11H22N2
- MW: 182.31
- EINECS:
- MDL Number:MFCD17214743
- Synonyms:(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine;3-Pyrrolidinamine, 1-(cyclohexylmethyl)-, (3R)-
5 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
Package
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01EVZE
- Product description(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95%
- Packaging100mg
- Price$207
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01EVZE
- Product description(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95%
- Packaging250mg
- Price$363
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01EVZE
- Product description(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95%
- Packaging1g
- Price$896
- Updated2026-05-30
- Buy
- ManufacturerChemenu
- Product numberCM520577
- Product description(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 97%
- Packaging1g
- Price$370
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11121675
- Product description(R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 97%
- Packaging1g
- Price$370
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01EVZE | (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95% | 100mg | $207 | 2026-05-30 | Buy |
| aablocks | AA01EVZE | (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95% | 250mg | $363 | 2026-05-30 | Buy |
| aablocks | AA01EVZE | (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 95% | 1g | $896 | 2026-05-30 | Buy |
| Chemenu | CM520577 | (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 97% | 1g | $370 | 2026-05-26 | Buy |
| Crysdot | CD11121675 | (R)-1-(Cyclohexylmethyl)pyrrolidin-3-amine 97% | 1g | $370 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




